These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 24304465)

  • 1. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
    Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
    Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
    Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
    Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.
    Thike AA; Chng MJ; Fook-Chong S; Tan PH
    Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
    Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
    Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
    Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
    Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Prostate-Specific Membrane Antigen (PSMA) Immunohistochemical Expression in Early-Stage Breast Cancer Subtypes.
    Andryszak N; Kurzawa P; Krzyżaniak M; Nowicki M; Ruchała M; Iżycki D; Czepczyński R
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Jiao D; Li Y; Yang F; Han D; Wu J; Shi S; Tian F; Guo Z; Xi W; Li G; Zhao A; Yang AG; Qin W; Wang H; Wen W
    Clin Transl Gastroenterol; 2019 May; 10(5):1-7. PubMed ID: 31116141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.
    Bos R; Zhong H; Hanrahan CF; Mommers EC; Semenza GL; Pinedo HM; Abeloff MD; Simons JW; van Diest PJ; van der Wall E
    J Natl Cancer Inst; 2001 Feb; 93(4):309-14. PubMed ID: 11181778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
    Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
    Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
    Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
    Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
    Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
    J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Specific Membrane Antigen (PSMA) Expression in The Neovasculature of High Grade Gliomas (Histopathological and Immunohistochemical Study).
    Abdel Maguid MS; Saad El Dine MG; Gabal SM; Abou Fandoud SM
    Asian Pac J Cancer Prev; 2023 May; 24(5):1797-1808. PubMed ID: 37247303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical categorisation of ductal carcinoma in situ of the breast.
    Meijnen P; Peterse JL; Antonini N; Rutgers EJ; van de Vijver MJ
    Br J Cancer; 2008 Jan; 98(1):137-42. PubMed ID: 18043578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.